| Proteogenomics connects somatic mutations to signalling in breast cancer P Mertins, DR Mani, KV Ruggles, MA Gillette, KR Clauser, P Wang, ... Nature 534 (7605), 55-62, 2016 | 1533 | 2016 |
| Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5′ sites S Schwartz, MR Mumbach, M Jovanovic, T Wang, K Maciag, GG Bushkin, ... Cell reports 8 (1), 284-296, 2014 | 1130 | 2014 |
| Integrated proteogenomic characterization of human high-grade serous ovarian cancer H Zhang, T Liu, Z Zhang, SH Payne, B Zhang, JE McDermott, JY Zhou, ... Cell 166 (3), 755-765, 2016 | 887 | 2016 |
| Integrated proteomic analysis of post-translational modifications by serial enrichment P Mertins, JW Qiao, J Patel, ND Udeshi, KR Clauser, DR Mani, ... Nature methods 10 (7), 634-637, 2013 | 649 | 2013 |
| High-resolution mapping reveals a conserved, widespread, dynamic mRNA methylation program in yeast meiosis S Schwartz, SD Agarwala, MR Mumbach, M Jovanovic, P Mertins, ... Cell 155 (6), 1409-1421, 2013 | 635 | 2013 |
| Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities S Vasaikar, C Huang, X Wang, VA Petyuk, SR Savage, B Wen, Y Dou, ... Cell 177 (4), 1035-1049. e19, 2019 | 560 | 2019 |
| A genome-wide CRISPR screen in primary immune cells to dissect regulatory networks O Parnas, M Jovanovic, TM Eisenhaure, RH Herbst, A Dixit, CJ Ye, ... Cell 162 (3), 675-686, 2015 | 502 | 2015 |
| Dynamic profiling of the protein life cycle in response to pathogens M Jovanovic, MS Rooney, P Mertins, D Przybylski, N Chevrier, R Satija, ... Science 347 (6226), 1259038, 2015 | 489 | 2015 |
| The translational landscape of the human heart S van Heesch, F Witte, V Schneider-Lunitz, JF Schulz, E Adami, AB Faber, ... Cell 178 (1), 242-260. e29, 2019 | 440 | 2019 |
| Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels P Mertins, F Yang, T Liu, DR Mani, VA Petyuk, MA Gillette, KR Clauser, ... Molecular & cellular proteomics 13 (7), 1690-1704, 2014 | 394 | 2014 |
| Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography–mass spectrometry P Mertins, LC Tang, K Krug, DJ Clark, MA Gritsenko, L Chen, KR Clauser, ... Nature protocols 13 (7), 1632-1661, 2018 | 385 | 2018 |
| Transcriptional and translational differences of microglia from male and female brains D Guneykaya, A Ivanov, DP Hernandez, V Haage, B Wojtas, N Meyer, ... Cell reports 24 (10), 2773-2783. e6, 2018 | 362 | 2018 |
| Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000 s of ubiquitination sites in single proteomics experiments ND Udeshi, T Svinkina, P Mertins, E Kuhn, DR Mani, JW Qiao, SA Carr Molecular & Cellular Proteomics 12 (3), 825-831, 2013 | 342 | 2013 |
| Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2 H Greulich, B Kaplan, P Mertins, TH Chen, KE Tanaka, CH Yun, X Zhang, ... Proceedings of the National Academy of Sciences 109 (36), 14476-14481, 2012 | 324 | 2012 |
| Large-scale identification of ubiquitination sites by mass spectrometry ND Udeshi, P Mertins, T Svinkina, SA Carr Nature protocols 8 (10), 1950-1960, 2013 | 310 | 2013 |
| Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy K Krug, EJ Jaehnig, S Satpathy, L Blumenberg, A Karpova, M Anurag, ... Cell 183 (5), 1436-1456. e31, 2020 | 306 | 2020 |
| TMT labeling for the masses: a robust and cost-efficient, in-solution labeling approach*[S] J Zecha, S Satpathy, T Kanashova, SC Avanessian, MH Kane, ... Molecular & cellular proteomics 18 (7), 1468-1478, 2019 | 296 | 2019 |
| Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition GS Wong, J Zhou, JB Liu, Z Wu, X Xu, T Li, D Xu, SE Schumacher, ... Nature medicine 24 (7), 968-977, 2018 | 232 | 2018 |
| Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition GS Wong, J Zhou, JB Liu, Z Wu, X Xu, T Li, D Xu, SE Schumacher, ... Nature medicine 24 (7), 968-977, 2018 | 230 | 2018 |
| CLCN2 chloride channel mutations in familial hyperaldosteronism type II UI Scholl, G Stölting, J Schewe, A Thiel, H Tan, C Nelson-Williams, ... Nature genetics 50 (3), 349-354, 2018 | 227 | 2018 |
